SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001384101-21-000173
Filing Date
2021-11-09
Accepted
2021-11-09 16:11:33
Documents
14
Period of Report
2021-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vcyt-20211109.htm   iXBRL 8-K 37703
2 EX-99.1 PRESS RELEASE 11-09-2021 vcyt-1109218xkearningsrele.htm EX-99.1 180706
6 GRAPHIC veracytelogor.jpg GRAPHIC 6442
  Complete submission text file 0001384101-21-000173.txt   385258

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcyt-20211109.xsd EX-101.SCH 1927
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vcyt-20211109_lab.xml EX-101.LAB 25298
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcyt-20211109_pre.xml EX-101.PRE 13202
7 EXTRACTED XBRL INSTANCE DOCUMENT vcyt-20211109_htm.xml XML 11872
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Filer) CIK: 0001384101 (see all company filings)

IRS No.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36156 | Film No.: 211392256
SIC: 8071 Services-Medical Laboratories